DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 077353
NDA 077353 describes ALLOPURINOL, which is a drug marketed by Accord Hlthcare, Apotex Inc, Fosun Pharma, Indoco Remedies, Ipca Labs Ltd, Mutual Pharm, Mylan, Northstar Hlthcare, Puracap Pharm, Purepac Pharm, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Vintage Pharms, Watson Labs, Zydus Pharms Usa Inc, and West-ward Pharms Int, and is included in twenty-five NDAs. It is available from forty suppliers. Additional details are available on the ALLOPURINOL profile page.
The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 077353
| Tradename: | ALLOPURINOL |
| Applicant: | Apotex Inc |
| Ingredient: | allopurinol |
| Patents: | 0 |
| Therapeutic Class: | Antigout Agents |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 077353
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Sep 8, 2005 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
| Approval Date: | Sep 8, 2005 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
